Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real‐life experience from a single tertiary center
Photodermatology, Photoimmunology & Photomedicine · 2023-09 · 39 (5) · 428-434
DOI: 10.1111/phpp.12872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, online erschienen am 26.03.2023. Verfasst von Pelin Ertop Doğan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Dermatology Department, Ankara University, 06230, Ankara, Turkey. Hauptthemen laut MEDLINE: Mycosis Fungoides, Skin Neoplasms, Photochemotherapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Mycosis fungoides (MF) is the most common cutaneous T‐cell lymphoma. Skin‐directed therapies, including phototherapy, are the first‐line treatment modalities. Psoralen plus ultraviolet A light photochemotherapy (PUVA) is quite effective in controlling the disease; however, long‐term adverse effects, particularly carcinogenesis, are the cons of this treatment.
Objective
There are various studies on the negative impact of PUVA on skin cancer in patients with autoimmune skin diseases. The data on the long‐term effects of phototherapy on MF patients are scarce.
Methods
All MF cases that received PUVA alone or combined with other treatments at a single tertiary center were analyzed. This study compared the development of non‐melanoma skin cancers, melanoma, and solid organ tumors in MF patients with at least 5‐year follow‐up data with age‐ and sex‐matched controls.
Results
A total of 104 patients were included in the study. Ninety‐two malignancies were detected in 16 (15.4%) patients, and six developed multiple malignancies. Skin cancers consisted of 56 basal cell carcinomas, 16 Bowen's disease, four squamous cell carcinomas, three melanomas, two basosquamous cell carcinomas, one Kaposi sarcoma, and one keratoacanthoma were found in nine (8.7%) patients. Eight patients developed three solid cancers and six lymphomas. The risk of developing skin cancer was associated with the total number of PUVA sessions (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Dermatology Department, Ankara University, 06230, Ankara, Turkey.
- Faculty of Medicine, Dermatology Department, Zonguldak Bulent Ecevit University, 67600, Zonguldak, Turkey.
- Department of Dermatology and Venereology, Koç University School of Medicine, 34010, Istanbul, Turkey.
ORCID-Profile: Pelin Ertop Doğan, Bengü Nisa Akay, Seçil Vural, Canan Arı, Tuğçe Ertürk Yılmaz
Zitieren
APA
Doğan, P. E., Akay, B. N., Vural, S., Arı, C., Yılmaz, T. E., & Şanlı, H. (2023). Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real‐life experience from a single tertiary center. Photodermatology, Photoimmunology & Photomedicine, 39(5), 428-434. https://doi.org/10.1111/phpp.12872
Vancouver
Doğan PE, Akay BN, Vural S, Arı C, Yılmaz TE, Şanlı H. Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real‐life experience from a single tertiary center. Photodermatology, Photoimmunology & Photomedicine. 2023;39(5):428-434. doi:10.1111/phpp.12872
BibTeX
@article{Doan2023,
author = {Doğan, Pelin Ertop and Akay, Bengü Nisa and Vural, Seçil and Arı, Canan and Yılmaz, Tuğçe Ertürk and Şanlı, Hatice},
title = {Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real‐life experience from a single tertiary center},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2023},
volume = {39},
number = {5},
pages = {428--434},
doi = {10.1111/phpp.12872}
}
EUVIMED